Pharma Journalist - Page 8 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub

Zealand Pharma Expands with New Cambridge Research Hub

Sanofi Licenses Kali’s Tri-Specific Antibody in $1B Deal

LGM Pharma Expands U.S. Manufacturing With $15M Investment

Excalipoint Raises $68.7M to Advance T-Cell Therapies

UK Streamlines Drug Approvals to Accelerate Patient Access

Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal

Vir Biotechnology and Astellas Announce $1.71B Partnership, Accelerating Innovation in PSMA‑Targeting TCEs

FDA Approves First Oral IL-23 Blocker for Psoriasis

Voro, Daiichi Sankyo Partner on Tumor-Activated ADCs